Question

research paper - 700-1000 words

please provide resources

Canadian biotechnology firm's entry strategy in the European Union market

A small Canadian firm that has developed some valuable new medical products using its unique biotechnology know-how is trying to decide how best to serve the European Union. Its choices are given below. The cost of investment in manufacturing facilities will be a major one for the Canadian firm, but it is not outside its reach. If these are the firm’s only options, which one would you advise it to choose? Why?

(i) Manufacture the product at home and let foreign sales agents handle marketing.

Answer 1

The Canadian organization has built up a historic and exceptionally respected clinical item that utilization's propelled biotechnology know-how to decide if to join the European Union.

a. The exportation of the item is a decision for the business when the item is created and marked in European Union. A business official can be upheld which would involve zero interest in the development of creation units in different nations.

b. The assembling of and offer of the items at home through the foundation of an entirely possessed backup reinforces the notoriety of and limit with respect to the organization to support its clients. This will involve a decent measure of interest in the foundation of the universal backup.

c. It is likewise an alternative to enter a collusion or joint endeavor with the European association gathering. In any case, this needs a generous expense in the development of creation offices abroad, which the organization can not bear.

Decision: Therefore, an entirely possessed backup is the most appropriate decision for the organization, which cost in particular as far as venture. Manufacture the products at home and set up a wholly owned subsidiary in Europe to handle marketing.is consequently the most profitable .

please give a like, if this answer helps you. Thank You.